These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 21358412

  • 1. Hormonal contraceptive use and HIV disease progression among women in Uganda and Zimbabwe.
    Morrison CS, Chen PL, Nankya I, Rinaldi A, Van Der Pol B, Ma YR, Chipato T, Mugerwa R, Dunbar M, Arts E, Salata RA.
    J Acquir Immune Defic Syndr; 2011 Jun 01; 57(2):157-64. PubMed ID: 21358412
    [Abstract] [Full Text] [Related]

  • 2. Hormonal contraceptive use and discontinuation among HIV-infected women in Uganda and Zimbabwe.
    Bengtson A, Kwok C, Salata RA, Byamugisha J, Chipato T, Rwambuya S, Moyo P, Morrison CS.
    J Acquir Immune Defic Syndr; 2013 Aug 01; 63(4):506-13. PubMed ID: 23572011
    [Abstract] [Full Text] [Related]

  • 3. Effects of hormonal contraceptive use on HIV acquisition and transmission among HIV-discordant couples.
    Lutalo T, Musoke R, Kong X, Makumbi F, Serwadda D, Nalugoda F, Kigozi G, Sewankambo N, Sekasanvu J, Wawer M, Gray R.
    AIDS; 2013 Oct 01; 27 Suppl 1():S27-34. PubMed ID: 24088681
    [Abstract] [Full Text] [Related]

  • 4. Associations of hormonal contraceptive use with measures of HIV disease progression and antiretroviral therapy effectiveness.
    Whiteman MK, Jeng G, Samarina A, Akatova N, Martirosyan M, Kissin DM, Curtis KM, Marchbanks PA, Hillis SD, Mandel MG, Jamieson DJ.
    Contraception; 2016 Jan 01; 93(1):17-24. PubMed ID: 26197261
    [Abstract] [Full Text] [Related]

  • 5. Effects of Depot Medroxyprogesterone Acetate, Copper Intrauterine Devices, and Levonorgestrel Implants on Early HIV Disease Progression.
    Morrison CS, Hofmeyr GJ, Thomas KK, Rees H, Philip N, Palanee-Phillips T, Nanda K, Nair G, Onono M, Mastro TD, Lind M, Heffron R, Edward V, Deese J, Beksinska M, Beesham I, Stringer JSA, Baeten JM, Ahmed K, ECHO Trial Team.
    AIDS Res Hum Retroviruses; 2020 Aug 01; 36(8):632-640. PubMed ID: 32394723
    [Abstract] [Full Text] [Related]

  • 6. A Longitudinal Assessment of Cervical Inflammation and Immunity Associated with HIV-1 Infection, Hormonal Contraception, and Pregnancy.
    Morrison CS, Fichorova R, Chen PL, Kwok C, Deese J, Yamamoto H, Anderson S, Chipato T, Salata R, Doncel GF.
    AIDS Res Hum Retroviruses; 2018 Oct 01; 34(10):889-899. PubMed ID: 30047279
    [Abstract] [Full Text] [Related]

  • 7. Oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial.
    Balkus JE, Brown ER, Hillier SL, Coletti A, Ramjee G, Mgodi N, Makanani B, Reid C, Martinson F, Soto-Torres L, Abdool Karim SS, Chirenje ZM.
    Contraception; 2016 Jan 01; 93(1):25-31. PubMed ID: 26519646
    [Abstract] [Full Text] [Related]

  • 8. Hormonal contraception and the risk of HIV acquisition.
    Morrison CS, Richardson BA, Mmiro F, Chipato T, Celentano DD, Luoto J, Mugerwa R, Padian N, Rugpao S, Brown JM, Cornelisse P, Salata RA, Hormonal Contraception and the Risk of HIV Acquisition (HC-HIV) Study Group.
    AIDS; 2007 Jan 02; 21(1):85-95. PubMed ID: 17148972
    [Abstract] [Full Text] [Related]

  • 9. Discontinuation of oral contraceptives and depot medroxyprogesterone acetate among women with and without HIV in Uganda, Zimbabwe and Thailand.
    Nanda K, Morrison CS, Kwok C, Byamugisha J, Jones L, Sriplienchan S, Magwali T.
    Contraception; 2011 Jun 02; 83(6):542-8. PubMed ID: 21570552
    [Abstract] [Full Text] [Related]

  • 10. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa.
    Myer L, Denny L, Wright TC, Kuhn L.
    Int J Epidemiol; 2007 Feb 02; 36(1):166-74. PubMed ID: 17175547
    [Abstract] [Full Text] [Related]

  • 11. Use of injectable hormonal contraception and women's risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda.
    Grabowski MK, Gray RH, Makumbi F, Kagaayi J, Redd AD, Kigozi G, Reynolds SJ, Nalugoda F, Lutalo T, Wawer MJ, Serwadda D, Quinn TC, Tobian AAR.
    Lancet Glob Health; 2015 Aug 02; 3(8):e478-e486. PubMed ID: 26094162
    [Abstract] [Full Text] [Related]

  • 12. Acquisition of Sexually Transmitted Infections among Women Using a Variety of Contraceptive Options: A prospective Study among High-risk African Women.
    Kiweewa FM, Brown E, Mishra A, Nair G, Palanee-Phillips T, Mgodi N, Nakabiito C, Chakhtoura N, Hillier SL, Baeten JM, MTN-020/ASPIRE Study Team.
    J Int AIDS Soc; 2019 Feb 02; 22(2):e25257. PubMed ID: 30816632
    [Abstract] [Full Text] [Related]

  • 13. Hormonal Contraception and Risk of Psychiatric and Other Noncommunicable Diseases in HIV-Infected Women.
    Castilho JL, Jenkins CA, Shepherd BE, Bebawy SS, Turner M, Sterling TR, Melekhin VV.
    J Womens Health (Larchmt); 2015 Jun 02; 24(6):481-8. PubMed ID: 25751720
    [Abstract] [Full Text] [Related]

  • 14. Hormonal contraception and HIV-1 disease progression among postpartum Kenyan women.
    Richardson BA, Otieno PA, Mbori-Ngacha D, Overbaugh J, Farquhar C, John-Stewart GC.
    AIDS; 2007 Mar 30; 21(6):749-53. PubMed ID: 17413696
    [Abstract] [Full Text] [Related]

  • 15. Hormonal contraception and the risk of HIV acquisition among women in South Africa.
    Morrison CS, Skoler-Karpoff S, Kwok C, Chen PL, van de Wijgert J, Gehret-Plagianos M, Patel S, Ahmed K, Ramjee G, Friedland B, Lahteenmaki P.
    AIDS; 2012 Feb 20; 26(4):497-504. PubMed ID: 22156973
    [Abstract] [Full Text] [Related]

  • 16. Contraceptive Use and Pregnancy Incidence Among Women Participating in an HIV Prevention Trial.
    Akello CA, Bunge KE, Nakabiito C, Mirembe BG, Fowler MG, Mishra A, Marrazzo J, Chirenje ZM, Celum C, Balkus JE.
    J Womens Health (Larchmt); 2017 Jun 20; 26(6):670-676. PubMed ID: 28437215
    [Abstract] [Full Text] [Related]

  • 17. Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception.
    Heffron R, Mugo N, Were E, Kiarie J, Bukusi EA, Mujugira A, Frenkel LM, Donnell D, Ronald A, Celum C, Baeten JM, Partners PrEP Study Team.
    AIDS; 2014 Nov 28; 28(18):2771-6. PubMed ID: 25493602
    [Abstract] [Full Text] [Related]

  • 18. Pregnancy risk among oral contraceptive pill, injectable contraceptive, and condom users in Uganda, zimbabwe, and Thailand.
    Steiner MJ, Kwok C, Dominik R, Byamugisha JK, Chipato T, Magwali T, Mmiro F, Rugpao S, Sriplienchan S, Morrison CS.
    Obstet Gynecol; 2007 Nov 28; 110(5):1003-9. PubMed ID: 17978111
    [Abstract] [Full Text] [Related]

  • 19. The Effect of Hormonal Contraception on Cervicovaginal Mucosal End Points Associated with HIV Acquisition.
    Thurman A, Chandra N, Schwartz JL, Brache V, Chen BA, Asin S, Rollenhagen C, Herold BC, Fichorova RN, Hillier SL, Weiner DH, Mauck C, Doncel GF.
    AIDS Res Hum Retroviruses; 2019 Sep 28; 35(9):853-864. PubMed ID: 30997816
    [Abstract] [Full Text] [Related]

  • 20. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina.
    Mostad SB, Overbaugh J, DeVange DM, Welch MJ, Chohan B, Mandaliya K, Nyange P, Martin HL, Ndinya-Achola J, Bwayo JJ, Kreiss JK.
    Lancet; 1997 Sep 27; 350(9082):922-7. PubMed ID: 9314871
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.